The Qatar Metabolic Institute (QMI) is a unique partnership between several leading education, research and clinical institutions in the State of Qatar. The common and unified goal is to work in collaboration to deliver significant improvements in health and disease outcomes for the Qatar population affected by diabetes, and metabolic diseases. The Institute Director is Professor Abdul Badi Abou Samra, Chairman of Internal Medicine at Hamad Medical Corporation, and Co-Chair of the National Diabetes Strategy 2016 – 2022, together with Dr. Al-Anoud Mohammed Al Thani, from the Ministry of Public Health (MoPH).
The Qatar Metabolic Institute was officially launched on the 1 May, 2016 by Her Excellency, Dr. Hanan Al Kuwari, Minister of Public Health, and the vision is to deliver world-class excellence in clinical services, education and research for diabetes, obesity and metabolic diseases. The QMI partnership includes: Hamad Medical Corporation (HMC), Weill Cornell Medical College (WCM-Q), Qatar University (QU), University of Calgary (UCQ), College of North Atlantic (CAN-Q), SIDRA Medical and Research Center, Qatar Biomedical Research Institute (QBRI), and the Primary Health Care Corporation (PHCC). Amongst the key objectives of the Institute, is to support the implementation of the Qatar National Diabetes Strategy, which includes raising patient and public awareness of diabetes, empowering patients to improve their health, supporting health care professionals to deliver new models of care, and ensuring that all this work is informed by the highest quality information and research evidence.